Nitrosamine Mitigation: A Path to Regulatory Compliance

In the wake of the Food and Drug Administration's (FDA's) latest guidance on nitrosamine contamination, ensuring compliance and safeguarding pharmaceutical products is more critical than ever. This ebook provides a comprehensive roadmap for understanding nitrosamine risks and offers actionable strategies to mitigate potential impurities. Through expert insights from Adare Pharma Solutions, you’ll learn how to remain compliant, identify risks, and implement cutting-edge strategies for nitrosamine mitigation.

Articles in this issue

---

Nitrosamine Mitigation: A Path to Regulatory Compliance

Related Content

Advertisement

July 25th 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

Lonza

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:

July 18th 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

Catalent

July 16th 2025

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Catalent

July 15th 2025

Rethinking Inhalation Drug Development

Experic

What it takes to bring complex inhaled therapies to market—faster and smarter.

July 15th 2025

CDMO Solutions – Reducing Risk and Accelerating Time to Market

Experic

Discover how our precision processes and dedicated personal support can expedite even the most complex drug programs.

July 15th 2025

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience

Experic

Related Content

Advertisement

July 25th 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

Lonza

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:

July 18th 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

Catalent

July 16th 2025

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Catalent

July 15th 2025

Rethinking Inhalation Drug Development

Experic

What it takes to bring complex inhaled therapies to market—faster and smarter.

July 15th 2025

CDMO Solutions – Reducing Risk and Accelerating Time to Market

Experic

Discover how our precision processes and dedicated personal support can expedite even the most complex drug programs.

July 15th 2025

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience

Experic